drugset / Trial / NCT00060801
Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients
Treatment
Summary
The purpose of this study is to determine the effect of 24 weeks of treatment with BIIL 284 BS compared with placebo on pulmonary function and incidence of pulmonary exacerbation in adult and pediatric cystic fibrosis patients.
Timeline
- Start
- 2003-05
- Primary completion
- 2004-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIIL 283 BS | Unknown | 75 mg | Oral |
| Subject | BIIL 283 BS | Unknown | 150 mg | Oral |